Generic Medicine Info
Previous or active peptic ulceration.
Special Precautions
Allergic disorders, coagulation defects; renal, cardiac or hepatic impairment; history of cardiac failure, left ventricular dysfunction, hypertension, or in patients with oedema due to other reasons; elderly, pregnancy and lactation. Feprazone should be withdrawn if GI lesions develop.
Adverse Reactions
GI disturbances and ulceration; hypersensitivity reactions, CNS effects, tinnitus, photosensitivity, haematuria; blood disorders, fluid retention, raised blood pressure.
Drug Interactions
Antidepressant, SSRIs and venlafaxine may increase risk of bleeding when given with NSAIDs. Risk of side effects increased with concomitant use of aspirin, ciclosporin, ketorolac or other NSAIDs. Lithium and methotrexate may increase risk of toxicity of NSAIDs. Effects of coumarins, phenindione, phenytoin and sulphonylureas are enhanced.
ATC Classification
M01AX18 - feprazone ; Belongs to the class of other non-steroidal antiinflammatory and antirheumatic products.
M02AA16 - feprazone ; Belongs to the class of non-steroidal antiinflammatory preparations for topical use. Used in the treatment of joint and muscular pains.
Disclaimer: This information is independently developed by CIMS based on feprazone from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in